| Literature DB >> 29487872 |
Hong Li1, Yi-Dan Li2, Wei-Wei Zhu2, Ling-Yun Kong2, Xiao-Guang Ye2, Qi-Zhe Cai2, Lan-Lan Sun2, Xiu-Zhang Lu2.
Abstract
Ultrasound lung comets (ULCs) are a nonionizing bedside approach to assess extravascular lung water. We evaluated a protocol for grading ULC score to estimate pulmonary congestion in heart failure patients and investigated clinical and echocardiographic correlates of the ULC score. Ninety-three patients with congestive heart failure, admitted to the emergency department, underwent pulmonary ultrasound and echocardiography. A ULC score was obtained by summing the ULC scores of 7 zones of anterolateral chest scans. The results of ULC score were compared with echocardiographic results, the New York Heart Association (NYHA) functional classification, radiologic score, and N-terminal pro-b-type natriuretic peptide (NT-proBNP). Positive linear correlations were found between the 7-zone ULC score and the following: E/e', systolic pulmonary artery pressure, severity of mitral regurgitation, left ventricular global longitudinal strain, NYHA functional classification, radiologic score, and NT-proBNP. However, there was no significant correlation between ULC score and left ventricular ejection fraction, left ventricle diameter, left ventricular volume, or left atrial volume. A multivariate analysis identified the E/e', systolic pulmonary artery pressure, and radiologic score as the only independent variables associated with ULC score increase. The simplified 7-zone ULC score is a rapid and noninvasive method to assess lung congestion. Diastolic rather than systolic performance may be the most important determinant of the degree of lung congestion in patients with heart failure.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29487872 PMCID: PMC5816880 DOI: 10.1155/2018/8474839
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1A linear probe was used to exclude noncardiac ULCs. (a) Normal pleura line and cardiac ULCs. (b, c) The abnormal pleural line could also generate ULCs (which are best visible under real-time examination), and they were confirmed by high-resolution computed tomography as interstitial lung disease and pneumonic infiltrate, respectively.
Radiologic score variables.
| Variables | Score | ||
|---|---|---|---|
| Mild | Moderate | Severe | |
| Hilar vessels | |||
| Enlarged | 1 | 2 | 3 |
| Increased in density | 2 | 4 | 6 |
| Blurred | 3 | 6 | 9 |
| Kerley lines | |||
| A | 4 | 8 | |
| B | 4 | 8 | |
| C | 4 | 8 | |
| Micronodules | 4 | 8 | |
| Widening of interlobar fissures | 4 | 8 | 12 |
| Peribronchial and perivascular cuffs | 4 | 8 | 12 |
| Extensive perihilar haze | 4 | 8 | 12 |
| Subpleural effusion | 5 | 10 | |
| Diffuse increase in density | 5 | 10 | 15 |
Figure 2Increasing severity of interstitial or alveoli involvement. (a) Normal lung; B-lines are absent. (b) Septal syndrome; B-lines are about 7 mm apart, corresponding to subpleural septa. (c) Interstitial-alveolar syndrome; B-lines are confluent. (d) White lung. B-lines have coalesced, resulting in an echographic lung field that is almost completely white.
Patients' clinical characteristics.
| Variables | Mean ± SD or number (%) |
|---|---|
| Subjects, | 93 |
| Age, y | 67 ± 14 |
| Gender, female/male | 32/61 |
| Body surface area, m2 | 1.8 ± 0.2 |
| Hypercholesterolemia | 40 (43) |
| Diabetes | 20 (22) |
| Previous MIa | 16 (17) |
| PCIb | 10 (11) |
| CABGc | 4 (4) |
| NT-proBNP, pg/ml | 11645 ± 11070 |
| Radiologic score | 13 ± 7 |
| NYHA functional class | |
| II | 28 (30) |
| III | 56 (60) |
| IV | 9 (10) |
| Cause of heart failure | |
| Coronary artery disease | 64 (69) |
| Hypertension | 14 (15) |
| Dilated cardiomyopathy | 7 (8) |
| Myocarditis | 4 (4) |
| Perinatal cardiomyopathy | 1 (1) |
| Autoimmunity cardiomyopathy | 1 (1) |
| Alcoholic cardiomyopathy | 2 (2) |
aMI: myocardial infarction; bPCI: percutaneous coronary intervention; cCABG: coronary artery bypass grafting.
Patients' echocardiographic characteristics.
| Variables | Mean ± SD |
|---|---|
| LV ejection fraction, % | 35.7 ± 7.8 |
| LV end-diastolic diameter, mm | 60.1 ± 7.4 |
| LV end-systolic diameter, mm | 47.4 ± 8.6 |
| LVEDV, mL/LVEDVindex, mL/m2 | 166.3 ± 47.5/93.4 ± 25.5 |
| LVESV, mL/LVESVindex, mL/m2 | 108.3 ± 38.7/60.9 ± 21.4 |
| LAV, mL/LAVindex, mL/m2 | 78.1 ± 21.2/44 ± 12 |
| SPAP, mmHg | 42.2 ± 10.3 |
| TAPSE, mm | 17.7 ± 4.3 |
| GLS, % | 9.2 ± 2.7 |
LV: Left ventricular; LVEDV: left ventricle end-diastolic volume; LVESV: left ventricle end-systolic diameter; LAV: left atrial volume; index: divided by BSA (body surface area); SPAP: systolic pulmonary artery pressure; TAPSE: tricuspid annular plane systolic excursion; GLS: global longitudinal strain.
Figure 3Correlation between ULC score and E/e′ (a) and systolic pulmonary artery pressure (SPAP) (b).
Figure 4Lung ultrasound and echocardiographic parameters of a patient with congestive heart failure. (a) Interstitial-alveolar syndrome was detected by lung ultrasound. (b) Mitral inflow showed E/A > 2. (c) Tissue Doppler early (e′) and late (a′) diastolic velocities were markedly reduced. (d) Peak TR velocity by CW Doppler; peak right ventricle to right atrial systolic pressure gradient is 47 mmHg. (e, f) Global longitudinal strain analysis was −16.1%. Note that the left ventricular ejection fraction was 55.3% (f).
ULC scores by diastolic function grade and left ventricle ejection fraction (LVEF).
| ULC score |
| ||
|---|---|---|---|
| LV diastolic function grade | Grade I | 5.6 ± 2.4 | <0.001 |
| Grade II | 8.4 ± 3.2 | ||
| Grade III | 10.3 ± 3.7 | ||
|
| |||
| LV ejection fraction (LVEF) | LVEF ≥ 40% | 8.5 ± 3.0 | 0.52 |
| LVEF 25–39% | 9.1 ± 3.8 | ||
| LFEF < 25% | 10.1 ± 4.4 | ||
Patients with ULC scores < 8 and ≥8.
| Variables | ULC score | | |
|---|---|---|---|
| <8 ( | ≥8 ( | ||
|
| 14.6 ± 4.5 | 22.7 ± 8.1 | <0.0001 |
| SPAP, mmHg | 35.2 ± 8.6 | 45.8 ± 9.3 | <0.0001 |
| GLS, % | 9.9 ± 2.2 | 9.1 ± 2.7 | 0.14 |
| LV ejection fraction, % | 36.3 ± 7.6 | 35.3 ± 8.0 | 0.55 |
| LVEDD, mm | 59.3 ± 7.6 | 60.6 ± 7.3 | 0.46 |
| LVEDVindex, mL/m2 | 91.6 ± 22.8 | 94.6 ± 27.3 | 0.57 |
| LAVindex, mL/m2 | 43.4 ± 13.4 | 44.6 ± 11.3 | 0.66 |
| TAPSE, mm | 18.9 ± 4.6 | 17.0 ± 4.0 | 0.06 |
| LV diastolic function grade | <0.05 | ||
| Grade I | 7 (19) | 1 (2) | |
| Grade II | 18 (49) | 26 (46) | |
| Grade III | 12 (32) | 29 (52) | |
| Mitral regurgitation | <0.001 | ||
| Mild | 27 (73) | 19 (34) | |
| Moderate | 8 (22) | 25 (45) | |
| Severe | 2 (5) | 12 (21) | |
| NYHA functional class | <0.001 | ||
| II | 20 (54) | 11 (20) | |
| III | 15 (41) | 33 (59) | |
| IV | 2 (5) | 12 (21) | |
| Age, y | 63.6 ± 13.7 | 70.1 ± 13.4 | <0.05 |
| NT-proBNP, pg/ml | 5046.2 ± 4325.3 | 15426.3 ± 12140.2 | <0.0001 |
| Radiologic score | 8.2 ± 4.4 | 15.7 ± 6.5 | <0.0001 |
Data are mean ± SD or number (%). SPAP: systolic pulmonary artery pressure; GLS: global longitudinal strain; LVEDD: left ventricle end-systolic diameter; LVEDV: left ventricle end-diastolic volume; LAV: left atrial volume; index: divided by body surface area; TAPSE: tricuspid annular plane systolic excursion; NYHA: New York Heart Association.
Figure 5ROC curves showing the diagnostic performance of E/e′ and SPAP for predicting ULC score ≥ 8. (a) ROC curve of the E/e′ and (b) ROC curve of the SPAP. SPAP: systolic pulmonary artery pressure.